Paul J. Leibson carries out multidisciplinary research, doing studies in Molecular biology and Transfection. Paul J. Leibson performs multidisciplinary study in the fields of Transfection and Molecular biology via his papers. His study in Effector extends to Immunology with its themes. His study ties his expertise on Biochemistry together with the subject of Effector. His Biochemistry study typically links adjacent topics like Peripheral blood mononuclear cell. His research on Peripheral blood mononuclear cell frequently connects to adjacent areas such as In vitro. As part of his studies on In vitro, he frequently links adjacent subjects like Fibroblast. His research on Fibroblast frequently links to adjacent areas such as Cell culture. Paul J. Leibson integrates many fields in his works, including Cell culture and Virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sequential Involvement of Lck and SHP-1 with MHC-Recognizing Receptors on NK Cells Inhibits FcR-Initiated Tyrosine Kinase Activation
Bryce A. Binstadt;Kathryn M. Brumbaugh;Christopher J. Dick;Andrew M. Scharenberg.
Immunity (1996)
Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes.
Andrew D. Badley;Julie A. McElhinny;Paul J. Leibson;David H. Lynch.
Journal of Virology (1996)
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Daniel D Billadeau;Jadee L Upshaw;Renee A Schoon;Christopher J Dick.
Nature Immunology (2003)
Signal transduction during natural killer cell activation: inside the mind of a killer.
Paul J Leibson.
Immunity (1997)
Genetic Evidence for Differential Coupling of Syk Family Kinases to the T-Cell Receptor: Reconstitution Studies in a ZAP-70-Deficient Jurkat T-Cell Line
Brandi L. Williams;Kathy L. Schreiber;Weiguo Zhang;Ronald L. Wange.
Molecular and Cellular Biology (1998)
Vav1 Dephosphorylation by the Tyrosine Phosphatase SHP-1 as a Mechanism for Inhibition of Cellular Cytotoxicity
Christopher C. Stebbins;Carsten Watzl;Daniel D. Billadeau;Paul J. Leibson.
Molecular and Cellular Biology (2003)
Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions
Christine M. Eischen;Christine M. Eischen;Timothy J. Kottke;Timothy J. Kottke;Luis M. Martins;Luis M. Martins;Guriqbal S. Basi;Guriqbal S. Basi.
Blood (1997)
Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis
Takashi Namekawa;Melissa R. Snyder;Jeng Hsien Yen;Brenda E. Goehring.
Journal of Immunology (2000)
Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor
Andrew D. Badley;David Dockrell;Margaret Simpson;Ron Schut.
Journal of Experimental Medicine (1997)
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells
Jadee L Upshaw;Laura N Arneson;Renee A Schoon;Christopher J Dick.
Nature Immunology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Pfizer (United States)
Mayo Clinic
Mayo Clinic
Mayo Clinic
ApoVax, Inc.
Mayo Clinic
University of California, San Diego
Mayo Clinic
Mayo Clinic
Duke University
New York University
University of Florida
Xi'an University of Technology
University of Valladolid
National Institutes of Health
Indiana University
University of Padua
Case Western Reserve University
Illinois State University
Duke University
Finnish Institute for Health and Welfare
London School of Hygiene & Tropical Medicine
University of California, San Francisco
Newcastle University
Linköping University
University of Poitiers